Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest Expense - DebtInterest Expense - DepositsInterest ExpensesInterest Income - Debt SecuritiesInterest Income - DepositsInterest Income - NetInterest Income - TotalInterest income - InvestmentsInvestment Banking IncomeInvestment Gain (Loss)Net Income towards Common StockholdersNon-Interest IncomeOperating ExpensesOther Non-Interest IncomeOther Operating ExpensesProfit After TaxProvisionsResearch & DevelopmentRevenueTax ProvisionsTax RateWages, Salaries and Other
Others
Ratios

Carter Bankshares (CARE) Research & Development (2020 - 2022)

Carter Bankshares' Research & Development history spans 3 years, with the latest figure at $1.6 million for Q4 2022.

  • For Q4 2022, Research & Development rose 83.12% year-over-year to $1.6 million; the TTM value through Dec 2022 reached $4.1 million, up 9.1%, while the annual FY2025 figure was $5.7 million, 15.84% up from the prior year.
  • Research & Development reached $1.6 million in Q4 2022 per CARE's latest filing, up from $833000.0 in the prior quarter.
  • In the past five years, Research & Development ranged from a high of $1.6 million in Q4 2022 to a low of $486000.0 in Q1 2020.
  • Average Research & Development over 3 years is $875500.0, with a median of $841500.0 recorded in 2022.
  • Peak YoY movement for Research & Development: soared 89.51% in 2021, then decreased 18.17% in 2022.
  • A 3-year view of Research & Development shows it stood at $731000.0 in 2020, then rose by 18.33% to $865000.0 in 2021, then soared by 83.12% to $1.6 million in 2022.
  • Per Business Quant, the three most recent readings for CARE's Research & Development are $1.6 million (Q4 2022), $833000.0 (Q3 2022), and $842000.0 (Q2 2022).